Atea Pharmaceuticals, Inc. · Brief

Next report

11 days

Nov 11 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

1 of 8≥ implied

Mar 6 '25±40.3%▼−0.33%×0.01

May 12 '25±17.3%▼−11.15%×0.64

Aug 7 '25±50.5%▼−2.31%×0.05

Q3 FY25±41.6%▼−12.57%×0.30

Jan 8 '26±24.5%▲+3.74%×0.15

Q1 FY26±18.1%▲+11.13%×0.62

May 12 '26±12.9%▼−16.91%×1.31

Q2 FY26±11.0%▲+0.20%×0.02

quarterimplied−55%0+55%realized×

Q2 FY26±11.0%▲+0.20%×0.02

May '26±12.9%▼−16.91%×1.31

Q1 FY26±18.1%▲+11.13%×0.62

Jan '26±24.5%▲+3.74%×0.15

Q3 FY25±41.6%▼−12.57%×0.30

Aug '25±50.5%▼−2.31%×0.05

2 older reports

May '25±17.3%▼−11.15%×0.64

Mar '25±40.3%▼−0.33%×0.01

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 11 report · est.

Bull2 of 3

3tracked funds holding AVIRN-PORT · Aug 31 '26

123managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

7 of 8recent reports where the move came in under the options implied rangeEarnings history

11 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

AVIR report session

No linked exposure.

Oct 28impliedImplied move: ±25.4% into Nov 11 earnings (Oct 28 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.